military combat. MRI of the lumbar spine revealed diffuse central canal and midlumbar lateral recess stenoses ( Fig. 1) . Upright long-cassette radiographs revealed severe sagittal imbalance, flattening of normal thoracic kyphosis, and lumbar lordosis-pelvic incidence mismatch (Fig. 2) . A lumbar decompression with T3-ilium deformity correction was recommended to alleviate the patient's symptoms. This was planned in a staged fashion with 1 day of rest between the 2 stages.
Operation
During the first operation, we performed T-12 through S-1 laminectomies, medial facetectomies, and posterior segmental instrumentation of T-12 to the ilium with Smith-Petersen osteotomies of L-2, L-3, and L-4. The estimated blood loss (EBL) was 3000 ml. The patient awoke at his neurological baseline; however, the second stage was delayed by 6 days due to development of reversible acute kidney injury and ileus, both of which were treated and resolved before the second procedure. The acute kidney injury was secondary to the presence of only 1 kidney and mild intraoperative hypotension that responded to colloid, packed red blood cells, and intravenous phenylephrine. The second stage was again uncomplicated, during which the planned T3-ilium instrumented correction was completed. The EBL during the second stage was 1800 ml. During the procedure, the patient received 5200 ml crystalloid, 750 ml 5% albumin, and 5 U packed red blood 
FIG. 2.
Preoperative lateral (A) and anteroposterior (B) standing long-cassette radiographs revealing sagittal imbalance with flat-back deformity (pelvic incidence, 50°; pelvic tilt, 29°; lumbar lordosis, 8°; sagittal vertical axis, positive 17 cm; and thoracic kyphosis, 18°). Postoperative lateral (C) and anteroposterior (D) studies showing improvement in sagittal balance with increased lumbar lordosis and thoracic kyphosis (pelvic incidence, 50°; pelvic tilt, 29°; lumbar lordosis, 25°; sagittal vertical axis, positive 5 cm; and thoracic kyphosis, 36°). The black lines indicate the preoperative and postoperative angles, and the dotted lines depict the sagittal and coronal balance. cells. The patient was maintained normotensive throughout the procedure without the use of pressor support, and hourly hemoglobin values were never less than 9.9 g/dl.
Postoperative Course
The patient awoke from the second stage of the procedure at his neurological baseline with intact vision. Six hours later, he complained of sudden-onset visual loss. On examination, he was found to have bilateral blindness with absent perception of light or hand motion. He was also noted to be disoriented to year and location with full body rigidity and a left facial droop. Intravenous levetiracetam was empirically administered, and the patient continued on maintenance therapy. Findings of a noncontrast CT scan of the head was negative for acute pathology. This was followed by MRI, MR angiography, and MR venography of the brain, the findings of which were all unremarkable (Fig. 3) . Results of a comprehensive altered mental status laboratory workup revealed no abnormalities. Carotid duplex and echocardiography findings were both normal. Routine electroencephalography (EEG) revealed slowing of the posterior background, but it did not reveal epileptiform discharges or seizure activity. Ophthalmology examination revealed a left pupil fixed at 3 mm and a right pupil fixed at 1 mm. The bilateral pupils briefly dilated when light was withdrawn and then slowly returned to their previous size without a light stimulus. Switching from dark to light exposure did not elicit pupillary dilation or constriction. A dilated funduscopic examination revealed intact bilateral anterior optic nerves and no abnormal retinal findings. Medication side effects were entertained to explain these findings, but no clear ophthalmological etiology could explain the pupillary findings.
As the ophthalmological examination results were inconclusive and the patient continued to be intermittently confused, continuous video-EEG was started 2 days after the second stage of surgery. This revealed bilateral occipital lobe seizures (Fig. 4) with an associated semiology of confusion and blindness only. Nystagmus and eye deviation were absent. The seizures temporarily stopped after the patient received 3 doses of intravenous lorazepam 2 mg, intravenous levetiracetam 1000 mg, and lacosamide 400 mg. However, the patient remained blind. Bioccipital electrographic status epilepticus recurred 1 hour later. The patient was therefore intubated, and a continuous intravenous infusion of midazolam was initiated with a loading dose of 0.2 mg/kg and continued at 0.1 mg/kg/hr with resolution of occipital status epilepticus. The midazolam infusion was slowly titrated off over 3 days with the patient maintained on a regimen of levetiracetam and lacosamide. No recurrent seizures were found on EEG. The patient was subsequently extubated and was found to have regained his baseline vision. The ophthalmology service found his visual acuity to be 20/40 in the right eye and 20/30 in the left eye without any field cuts. The patient is presently less than 1 year out of surgery; his construct is stable and his vision remains intact.
Discussion
POVL is a devastating complication after any surgery.
It is most frequently reported after spine and cardiac surgery with estimates of 0.2% and 4.5%, respectively.
11,13
Etiologies for POVL after spine surgery include AION, PION, central retinal artery occlusion, PRES, and cortical blindness due to posterior cerebral artery territory ischemia. The American Society of Anesthesiologists POVL Registry reports that AION and PION account for 89% of cases of POVL after spine surgery. 8 The Perioperative Visual Loss Study Group found that independent risk factors of AION and PION were male sex, obesity, use of the Wilson frame, prolonged duration of surgery, significant blood loss, and a low colloid-to-crystalloid administration ratio. 9 Pituitary apoplexy following spine surgery has been reported to cause postoperative bitemporal hemianopia but not complete blindness. 2 To our knowledge, this is the first reported case of occipital lobe status epilepticus causing complete blindness after spine surgery.
Reported cases of SEA are also rare. Barry et al. 3 reported a case series of 5 patients with SEA, 3 of whom were completely blind. The remaining patients experienced a homonymous hemianopia. Varied etiologies of the seizures in the 3 cases of complete blindness were implicated (1 occipital vascular lesion, 1 occipital neoplasm, and 1 was regarded as idiopathic).
Shaw et al. 12 described 3 patients with seizure histories (only 2 with epilepsy) who developed SEA that manifested as homonymous hemianopia. None of their patients had undergone surgery. All 3 patients returned to their visual baseline over several weeks with antiepileptic drugs. Compared with these 3 patients, our patient did not have a history of epilepsy, and SEA was not observed on MRI. Other authors have reported SEA to occur idiopathically, which is the scenario in this case.
Occipital Lobe Seizures
Occipital lobe epilepsy accounts for 5%-10% of all epilepsies and may present at any age, except for idiopathic occipital lobe epilepsy, which begins in childhood. Ictal symptoms are visual and/or oculomotor. Tonic deviation of the eyes remains the most common oculomotor manifestation, often combined with ipsilateral turning of the head. Nystagmus and repetitive eyelid closure or eyelid fluttering are also commonly observed.
1 Visual symptoms include visual hallucinations and illusions, sensory hallucinations of ocular movements, palinopsia, and both positive and negative phenomena. 1 Positive features include flashes and scintillations. Although rare, negative manifestations such as cortical blindness can occur. Seizures may be unilateral or bilateral and therefore present with homonymous hemianopia or complete ictal blindness, respectively. Occipital seizures may last seconds to minutes, with SEA being much less common. Visual loss in seizing patients can persist from days to weeks without cognitive dysfunction and may be associated with scintillations, diplopia, and simple motor seizures. Vision typically returns to baseline with aggressive anticonvulsant treatment. Although not clearly defined in cases of SEA, permanent neurological deficit is known to be associated with untreated status epilepticus elsewhere in the brain due to cortical laminar necrosis of the affected gyri. 
Anesthesia, SEA, and POVL
The effect of anesthesia in patients with intractable partial epilepsy undergoing surgery has previously been evaluated, but the incidence of clinical seizure activity in individuals without epilepsy in response to general anesthetic agents remains unknown.
14 Because certain anesthetic medications carry a proconvulsant effect, it is necessary to understand the consequences of their use in patients with epilepsy in whom general anesthesia is induced. Epileptiform activity has been demonstrated on EEG in patients receiving anesthetic agents, but clinical or electro- graphic seizures are rare. Anesthetic medications which may lower seizure threshold include the inhaled volatile anesthetics (enflurane, sevoflurane), local anesthetics (lidocaine, bupivacaine), opiates (fentanyl, sufentanil, alfentanil, meperidine), and even sedative/hypnotic anesthetics including etomidate, ketamine, and methohexital. 4 The use of motor evoked potentials carries with it the theoretical risk of inducing postoperative seizures in patients without a seizure history. This, however, is an extremely rare phenomenon and would more likely involve the corticospinal tracts and not the occipital cortex. 5 
SEA Management
SEA can initially be managed with benzodiazepines, followed by the intravenous administration of levetiracetam, valproic acid, or phenytoin. For status epilepticus, a continuous infusion of either midazolam or propofol with intubation and hemodynamic support using intravenous fluids and vasopressors should be initiated. These are the measures that were undertaken in our patient. Pentobarbital, ketamine, and high volatile anesthetics (isoflurane, desflurane, halothane) can be used for refractory and super-refractory status epilepticus. 
Conclusions
POVL is a devastating and rare complication associated with cardiac and spine surgery. The most common etiologies are AION and PION. Occipital lobe seizures and SEA presenting as complete blindness may represent an etiology for POVL and should be considered in patients regardless of seizure history. Clinical suspicion is raised if seizure semiology is accompanied by altered mental status, eye deviation, or body shaking and rigidity. Continuous EEG is required for diagnosis, as routine EEG may not capture nonconvulsive seizures and SEA. Treatment with antiepileptic drugs should be initiated for occipital lobe seizures and may require intubation for continuous intravenous infusions (midazolam, pentobarbital, ketamine, volatile anesthetics) if SEA develops.
This report describes SEA as a novel cause of POVL that requires a heightened degree of clinical suspicion. If left untreated, SEA may result in permanent visual loss. However, as demonstrated in this case report, early recognition and aggressive antiseizure treatment can result in an excellent outcome.
